-
Posted by
Two Blokes Jul 1 -
Filed in
Stock
-
9 views
TAMPA, Fla. , July 1, 2025 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immune-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, today announced that the Company has been added to the Russell 3000\u00ae Index, with automatic inclusion in the Russell 2000\u00ae Index, as a part of the 2025 Russell indexes annual reconstitution.
